ALMS logo

ALMS
Alumis Inc.

1,090
Mkt Cap
$3.09B
Volume
4.03M
52W High
$30.60
52W Low
$2.76
PE Ratio
-8.35
ALMS Fundamentals
Price
$25.06
Prev Close
$25.38
Open
$24.84
50D MA
$26.18
Beta
0.86
Avg. Volume
1.31M
EPS (Annual)
-$2.86
P/B
8.71
Rev/Employee
$107,366.07
$558.22
Loading...
Loading...

About

Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
224

Frequently Asked Questions

What is Market Cap of Alumis Inc.?
What is the 52-week high for Alumis Inc.?
What is the 52-week low for Alumis Inc.?
What is Alumis Inc. stock price today?
What was Alumis Inc. stock price yesterday?
What is the PE ratio of Alumis Inc.?
What is the Price-to-Book ratio of Alumis Inc.?
What is the 50-day moving average of Alumis Inc.?
How many employees does Alumis Inc. have?

Latest ALMS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.